The call for abstracts to NFS 2026 is now open.
At NFS 2026 we want to offer the opportunity for researchers to present their work to international colleagues in a Nordic setting. Submitting an abstract to NFS 2026 is a great way for researchers, particularly early-career researchers and others, to disseminate their research-findings. A prize will be awarded for the best abstract.
The submitted abstracts will be reviewed by the local organizing committee who will call on external scientific consultants for additional review if required. The outcome of the review process is either
a) accepted for oral presentation AND poster b) accepted for poster only c) rejected.
15th March 2026 at 23:59 CET
15th April 2026 at 23:59 CET
We welcome abstracts from research on the clinical science and medical aspects of reproductive physiology, pathology,epidemiology and endocrinology; including andrology, gonad function, gametogenesis, fertilization, embryo development, implantation, early pregnancy, reproductive genetics, genetic diagnosis, oncology, infectious disease, surgery, contraception, infertility treatment, psychology, ethics and social issues, quality-control, management of IVF-units.
Please note that we will reject abstracts concerning planned studies without current results.
Maximum 400 words
English
Should not exceed 25 words and should be specific and informative. Trade marks and proprietary terms are not allowed in the title.
Give initials and family name of all authors with author affiliations and addresses: The department, institution, city and country should be given for each author. An e-mail address must be stated for the corresponding author, who should be clearly identified with an asterisk. A back-up corresponding author should also be clearly identified and their e-mail address stated.
Summary of the study, maximum 400 words.